Subscribe To
89bio, inc.: a big bet on nash
89bio, Inc. is a clinical-stage biotech company focused on developing therapies for liver and cardio-metabolic diseases. The stock surged after top-li...
August 10, 2023, 1:48 pm
Galera therapeutics shares plummet after fda rejects drug for cancer treatment side effect
Galera Therapeutics shares plunged by almost 85% after the clinical-stage biopharmaceutical company revealed its New Drug Application for its investig...
August 10, 2023, 1:04 pm
Usd/jpy: phase of bounce could extend towards 146.10 – socgen
USD/JPY has embarked on a steady rebound after defending the upper part of previous consolidation zone near 138/137. It is approaching the peak of Jun...
August 10, 2023, 11:14 am
Werewolf therapeutics reports second quarter 2023 financial results and provides business update
– phase 1/1b clinical trial for IL-2 INDUKINE™ WTX-124 progressing in patients with advanced or met...
August 10, 2023, 11:10 am
Hookipa pharma reports second quarter 2023 financial results and recent business highlights
HOOKIPA reported positive preliminary phase 2 data on HB-200 in combination with pembrolizumab in 1st-l...
August 10, 2023, 11:01 am
Applied therapeutics reports second quarter 2023 financial results
Regulatory progress for govorestat (AT-007) for the treatment of Classic Galactosemia, with potential NDA submission based on discussions with the FDA...
August 10, 2023, 11:00 am
Prophase labs announces updated conference call dial-in information for thursday august 10, 2023 at 11:00 a.m. eastern time for second quarter 2023 financial results call.
Garden City, NY, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Prophase Labs, Inc. (NASDAQ: PRPH) Conference Call a...
August 10, 2023, 10:40 am
X4 pharmaceuticals reports second-quarter 2023 financial results, provides corporate updates, and reports emerging data from chronic neutropenia clinical program
Submission of first U.S. New Drug Application for mavorixafor in WHIM syndrome on track for early 2H 2023 Emerging data from ongoing ...
August 10, 2023, 10:05 am
Usdcad daily analysis – august 10, 2023
USDCAD is currently in a consolidation phase for the uptrend from 1.3092. There is a possibility of ran...
August 10, 2023, 8:30 am
Addex reports 2023 half year and second quarter financial results and provides corporate update
ADX71149 phase 2 epilepsy clinical study Cohort 2 continues recruiting following the Independent Interi...
August 10, 2023, 5:14 am
Bradda head lithium counts down to new drilling in arizona
Bradda Head Lithium Limited (AIM:BHL, OTCQB:BHLIF, TSX-V:BHLI) told investors that the drill rig has now been mobilised for ...
August 10, 2023, 3:58 am
Gbp/usd forecast: consolidates as support holds firm
During Tuesday’s trading session, the gbp/usd experienced a slight decline, further extending the ongoing consolidation phase. Tr … The post Gbp/U...
August 9, 2023, 7:29 pm
Tantalex lithium resources confirms ‘transformational' step as titan plant commissioning begins
Tantalex Lithium Resources (CSE:TTX) told investors that its majority-owned subsidiary United Cominiere SAS has started commissioning on its TiTan pla...
August 9, 2023, 10:05 am
Markets turned cautious after after china’s deflation data
Asian markets exhibited mild risk-off sentiment today, but with limited selloffs observed. China’s data revealed a foray into deflation, though expe...
August 9, 2023, 6:20 am
Usdcad daily analysis – august 9, 2023
USDCAD has extended its upside move from 1.3092 to reach as high as 1.3501 before experiencing a pullback. The subsequent pullback suggests that a con...
August 9, 2023, 2:10 am
3 massively undervalued blue-chip stocks for high total returns
It's worth noting that blue-chip stocks go through their own bull and bear phase. Nvidia (NASDAQ: NVDA ) was under-performing until October 2022....
August 8, 2023, 9:55 pm
Anika reports second quarter 2023 financial results
Double Digit Q2 Revenue Growth Driven by Strong OA Pain Management Growth of 22%; Raising Low-End of Full-Year Guidance Range on Positive Year-to-Date...
August 8, 2023, 8:05 pm
Aim immunotech announces completion of enrollment in phase 2 study evaluating ampligen® for the treatment of post-covid conditions
Topline data expected as early as Q1 2024 OCALA, Fla., Aug. 08, 2023 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM”) today a...
August 8, 2023, 12:05 pm
Why is biophytis (bpts) stock up 18% today?
Biophytis (NASDAQ: BPTS ) stock is soaring higher on Tuesday as investors react to a positive opinion for its upcoming ...
August 8, 2023, 7:48 am
Gevo’s net-zero 1 reaches key milestone for loan guarantee from the u.s. department of energy
ENGLEWOOD, Colo., Aug. 07, 2023 (GLOBE NEWSWIRE) — Gevo, Inc. (NASDAQ: GEVO) announced today that its Net-Zero 1 ethanol-to-jet project has been inv...
August 7, 2023, 1:00 pm